lyse plaque morphology and structure. We used the technique to treat 83 stenotic lesions in 75 patients. The study aims to describe and discuss our experience.
Introduction
Endovascular stenting a well-established less invasive alternative to thrombendarterectomy (TEA) in the treatment of extracranial carotid artery atheromasic stenosis, namely in symptomatic high-risk surgical candidates 1-5 . Stenting is also a safer primary treatment than angioplasty as it has a lower incidence of adverse events like plaque fragmentation, arterial dissection and acute carotid artery occlusion. Stenting will also establish a more definitive vessel lumen thereby lowering the incidence of subsequent restenosis due to neointimal hyperplasia typical of angioplasty alone 6,7 .
Most operators currently combine carotid stenting with angioplasty either before or after dilating the site of stenosis or only after dilatation.
The advent of technically advanced dedicated carotid artery stents has made it easier for operators to manoeuvre and position stents, shortening procedure times without relinquishing control. In addition, self-expanding carotid stents have significant radial force. Despite these advances, transient or permanent neurologic events responsible for major or minor ischaemia due to embolism or hemodynamic fac-
Summary
Endovascular stenting is a consolidated alternative to thrombendarterectomy in the treatment of extracranial carotid artery atheromasic stenosis.
The most common complication of stenting is a distal embolism causing clinically silent or symptomatic cerebral ischaemia. To prevent this complication distal embolism protection devices are often used but their effectiveness remains unsettled. In addition, there is some evidence that distal embolism may actually be triggered by the protection systems due to clot formation at their distal surface or in the intimal lesions these systems cause. Another rarer complication is hyperperfusion syndrome arising during both stenting and thrombendarterectomy but more common in endovascular procedures. To avoid these complications the Neuroradiology Service at Bellaria Hospital (Bologna Local Health Trust) has devised a mini-invasive carotid stenting technique that does not require either distal embolism protection or angioplasty.
The technique uses only the radial force exerted by the self-expanding stent to widen the atherosclerotic stenosis slowly and gradually. The goal of treatment has also changed from a prompt restoration of the atheromasic vessel's original calibre to slow transformation of the hemodynamic significance of the stenosis. The technique's success lies mainly in selecting the stenosis to treat using CT angiography to ana-154 tors (hypo or hyperperfusion) still represent a therapeutic challenge. Most of these events involve embolic infarcts (micro or macroemboli) generated in the most hazardous stages of the endovascular procedure, i.e. the passage of the guidewire through the stenosis, predilation, stent positioning and postdilation. Unfortunately current literature reports fail to distinguish the complications caused by stenting from those due to angioplasty. To have a rough evaluation we must go back to the time of angioplasty alone before the advent of stenting when the complication rate of angioplasty without filter was around 10%. Nowadays the complication rate of angioplasty with stenting and filtering is around 3,3%.
To prevent complications various protection systems are used, most commonly the filter protection device. However, the success of filter protection is linked to factors intrinsic to the filter itself (its profile, capacity to control the system, diameter of the open filter and its length and pore size) and extrinsic factors (ability of the filter to work in tortuous carotid axes, likelihood of carotid spasm) and lastly to factors linked to filter withdrawal. In addition, there have been some reports of filter-induced intimal and subintimal histological damage influencing the number of intracerebral embolic events 8-14 .
This paper describes a cohort of patients treated by carotid stenting at the Neuroradiological Service at our hospital. Most of our patients were treated by a mini-invasive carotid stenting procedure we devised which does not require either prior/post dilation or mechanical protection devices. In our opinion this approach avoids angioplasty-related complications.
Material and Methods
We retrospectively reviewed all carotid stenting procedures undertaken between January 2000 and December 2007 at the Neuroradiology Service of Bellaria Hospital, Bologna. The diagnosis of carotid artery stenosis had been established in all patients by echo Doppler examination and confirmed by CT angiography using multislice systems (Philips, GE and Siemens) to study the state of the arterial wall, plaque morphology and the vascular anatomy of the supraortic arteries to determine the endovascular approach. 
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Patients were selected following these major criteria: stenosis exceeding 70% or unstable symptomatic plaque, calcification of the plaque limited to part of the lesion 53 . Circumferential plaque not allowing stent dilatation is considered, in our series, an indication for a surgical approach. CT is the best imaging system to obtain this information. Examination yielded an accurate in vivo anatomopathological reconstruction of the stenotic site, subsequently confirmed prior to treatment in all cases by biplanar angiography using a GE device. CT angiography disclosed sites of ulcerated plaque in 12 patients, subsequently confirmed by angiography.
We treated 75 patients (53 men; 22 women), average age 69.5 years (range 53-89), positioning 83 stents. Our case series is an intention to treat selected patients.
The endovascular treatment was done after restenosis following surgical thrombarterectomy in nine patients, whereas the remainder had primary carotid stenting. All the remaining stenoses were hemodynamically significant and around half of the lesions were subocclusive. Seven patients (6 men, 1 woman) were treated bilaterally. Two stents were placed on the same side in one patient: one in the common carotid artery, the other in the internal carotid artery. Two stents were positioned during the same interventional session in four patients, and in four separate sessions in the remainer. All the remaining patients underwent monolateral stenting. A single stent was positioned astride a double consequential carotid stenosis (tandem le-sions) in two patients. Six patients had intracranial aneurysms (tandem lesions), four of which were embolized during the same interventional session. Three patients were treated using a radial approach (figure 1,2). Most procedures were carried out under local anaesthesia in the presence of an anaesthesist. The four patients who underwent embolization of an intracranial aneurysm received general anaesthesia.
Medical management after the endovascular procedure differed according to the treatment underway before stenting. Most patients receiving anti-aggregant therapy were given a bolus of heparin (5000 units) during stenting followed by enoxeparin (4000 units) for two days after the procedure, ticlopidine (250 mg x 2), acetylsalicylic acid (0.3 g x 1) and omeprazole for one month post-treatment, and only aspirin (250 g x 1) for the following six months. Patients receiving oral anticoagulants (warfarin) were not given the heparin bolus during the procedure but only aspirin 1 g i.v. The previous anticoagulant therapy was resumed after stenting in addition to acetylsalicylic acid (0.3 g x 1) and omeprazole for six months.
Two carotid access techniques were mainly used. The first required an 8F guiding catheter (Cordis Neurovascular FL, Boston Scientific CA) with a straight or slightly curved tip depending on the vascular anatomy, positioned in the common carotid artery through which the stent was inserted. The second technique, in use from January 2005 to reduce the diameter of the guiding catheter, is based on a 90 cm long 6F calibre long introducer (Destination Terumo Corporation, Japan) with a wide internal lumen (0.97 mm) inserted on an exchange guidewire directly in the common carotid artery.
No predilation was necessary to pass the stenosis. Self-expandable carotid Wallstent stents (Boston Scientific, CA) were inserted in all patients except two treated at the outset with Cerebrance stents. When the stent showed poor adherence to the vessel wall post-stenting dilation was done dilating only the stent and not the vessel wall (one case).
After post-treatment angiographic control, AP and LL radiograms were done to display stent morphology, site and degree of dilation.
All patients underwent follow-up examination by an independent neuroradiologist (RM) and an independent external physician (FG) expert in EchoColorDoppler examinations who performed the follow-up check comparing stent self-expansion and permeability, with respect to the end of treatment angiogram, at one, three and six months after endovascular treatment. We devised a personal assessment scale to score the degree of expansion obtained: -score 0: lack of hemodynamic transformation of the stenosis; -score 1: non hemodynamic plaque transformation with not less than 40% residual stenosis; -score 2: non hemodynamic plaque transformation with from 20 to 40% residual stenosis; -score 3: non hemodynamic plaque transformation with less than 20% residual stenosis. 
Results
Only one technical failure was encountered among the 83 endovascular procedures. This patient presented a large ulcerated plaque at the left carotid bifurcation and a subocclusive stenosis about 2 cm from the origin of the right internal carotid artery with signs of reduced right cerebral blood flow with compensation from the circle of Willis, the vertebral and left carotid arteries. A Stent was successfully deployed on the left and controlateral stenting was attempted but failed as a vessel dissection was seen with its definitive occlusion. No deficits were observed on clinical neurological follow-up 24h after the procedure. No major or minor ischaemic events or hyperperfusion syndromes were encountered.
Long-term clinical follow-up disclosed two patients who had had transient ischaemic events controlateral to the site of carotid stent deployment, four patients had died from cancer and one patient from acute myocardial infarction. Radiological follow-up was done in 70 patients as 13 failed to present at follow-up visits. The x-ray and EchoColorDoppler assessment yielded the following score: Score 0 (no results): three patients; two asymptomatic stent occlusion (figures 8-10); one post-stenting restenosis treated by angioplasty with cutting balloon (figures 11-13). Score 1: non hemodynamic plaque transformation with not less than 40% residual stenosis: 25 patients. Score 2: non hemodynamic plaque transformation with from 20 to 40% residual stenosis: 30 patients. Score 3: non hemodynamic plaque transformation with less than 20% residual stenosis: 12 patients.
Discussion
Carotid stenting has become an alternative to thrombendarterectomy (TEA) in the treatment of carotid atheromasic disease 15-17 . In addition to post-TEA restenosis, post-attinic stenosis and primary stenosis in high risk surgical candidates, the good results obtained with carotid stenting have broadened the indications for endovascular treatment to patients with primary stenosis.
The main criticism levelled against stenting as opposed to TEA is the higher risk of distal embolism from plaque detachment after widening the passageway. To avoid this complication various distal embolism protection devices types have been devised:
Balloons to stop blood flow in the internal carotid artery;
Filters allowing blood flow through the filter pores, withholding any fragments of plaque;
Parodi-type inversion of normal blood flow in the internal carotid artery.
Most operators currently use a distal protection device even though their effectiveness remains unsettled. Legal considerations play an important role in opting to use a protection system. Some literature reports claim the benefits of protection devices whereas others are criti- cal 18-32 . Much of this research consists of an analysis of the presence and quantity of material filtered by the protection system after the procedure, or monitoring the cerebral microembolism during endovascular treatment using multifrequency transcranial Doppler which can distinguish solid from gas emboli.
Other studies have used MR DWI before and after endovascular treatment to disclose any cerebral ischaemic events, including silent lesions 33 . So-called silent ischaemic events seem to determine a progressive impairment of cognitive functions in elderly patients leading to dementia in the severest cases 34, 35 . Protection systems do not seem able to withhold all plaque fragments in cases of massive embolism resulting in multiple distal ischaemia. In addition new ischaemic cerebral lesions have been disclosed even when no material had been filtered by the protection device 36 . This evidence has given rise to a number of pathogenetic theories such as the formation of emboli in distal surface of the protection device and in intimal lesions due to arterial wall contact with the balloon or filter protection device. Whether they favour the use of protection devices or not, most operators agreed on the need to combine carotid stenting with angioplasty ei-ther as a pre and post-dilation procedure or only post-dilation. Angioplasty represents the most traumatic stage of the endovascular procedure when the atherosclerotic plaque is disrupted with rapid restoration of vessel calibre. Plaque rupture can free fragments of plaque even after stent deployment despite its containment effect. In addition, angioplasty can lead to bradycardia and hypotension both during and after the procedure requiring atropine administration before dilation. The prompt restoration of normal vessel calibre produced by angioplasty and TEA can be complicated by hyperperfusion syndrome. This complication may arise during both stenting and TEA but is more common in endovascular procedures [37] [38] [39] [40] [41] [42] [43] [44] [45] . One explanation for this may be the greater anticoagulant and antiaggregant situation present during stenting to avoid any complications of angioplasty and protection devices. Hyperperfusion injury can arise with or without cerebral hemorrhage after a delay of five to seven days 46 , or occur several hours after surgery 47 or endovascular treatment. The severest forms are associated with bleeding, especially early hemorrhage, which may be fatal. Another pathogenetically different type of cerebral hemorrhage may also occur after restoration of normal vessel calibre. This bleed does not arise in the hemodynamically impaired territory, as would be expected in hyperperfusion syndrome, but in the basal nuclei. It may be caused by rupture of the perforating arteries in the basal ganglia following a sudden normaliza-tion of perfusion pressure thus patients with hypertensive microangiopathy at greater risk 48 .
We have devised a primary stenting technique different from the classic procedures or techniques modified to incorporate protection devices [49] [50] [51] [52] . Our approach does not require either angioplasty or distal embolism protection. The goal of treatment has also changed from prompt restoration of normal carotid calibre to slow transformation of the hemodynamic significance of the stenosis. Stenting will stabilize the hemodynamic situation over time. We found that the radial force exerted by deployment of a self-expanding Wallstent (Boston Scientific) in selected patients with severe stenosis would progressively widen the stenosis, remodelling the vessel lumen. The presence of ulcerated plaque did not affect the treatment as blood is trapped within the ulceration and thrombosis occurs after the stent is positioned ( figure 3-7) . A hemodynamically significant positive outcome was obtained in most of our patients in the three days after stent deployment with further widening of the stent at one and three month follow-up and in rare cases after six months. Our stenting technique is based on the following considerations:
The procedure is quick and relatively straightforward. Once the guiding catheter or introducer has been positioned 90 cm into the common carotid artery, stent deployment lasts from five to ten minutes. The progressive widening of the atherosclerotic plaque due to self-expansion of the stent limits damage to the plaques thereby reducing the risk of embolism and obviating the need for protection devices. Cerebral blood flow is increased and perfusion pressure normalized slowly thereby gradually reducing the possibility of either hyperperfusion syndrome or hemorrhage in the basal nuclei.
The rationale of the procedure is supported by the lack of major or minor ischaemic events, hyperfusion syndrome or hemorrhage in the basal ganglia never observed in our series.
The success of this endovascular approach lies mainly in selecting the stenosis to treat. CT angiography (CTA) is used to analyse plaque morphology, size and structure and the degree of carotid artery stenosis and confirmed by echo colour Doppler findings. CTA analyses the composition of the atheromasic plaque disclosing the prevalence of soft and calcified tissue, and measures the morphology and extension of the atherosclerotic lesion and the resid- ual carotid lumen. In addition to details on the plaque, CTA also studies the aortic arch and the origin of the epiaortic vessels yielding important information in planning endovascular treatment and disclosing any tandem lesions. Excluded from endovascular treatment are patients with pre-occlusive stenosis (namely those with soft plaque) requiring predilation before stent deployment and patients with concentric calcified lesions for which the radial force of the stent alone is not deemed sufficient to dilate the stenosis. If there is a major discrepancy between CT angiography and EchoColor-Doppler findings or any hemodynamic compensatory circulation requires assessment, patients are reselected by angiography.
-In our experience a month is required to determine whether the stent has sufficiently reduced the stenosis.
-Even though self-expanding stent placement may not sufficiently reduce the stenosis, it will increase cerebral perfusion ( figure 5,9 ). The gradual increase in cerebral flow reduces the risk of hyperfusion syndrome or hemorrhage in the basal nuclei during angioplasty;
-The stent should be re-epithelized; -The twofold antiaggregation maintained for one month, followed by five months of car-dioaspirin protects from microembolism and intrastent thrombosis.
Conclusions
Our mini-invasive carotid stenting technique avoids either distal embolism protection or angioplasty and has proved relatively straightforward and effective in selected patients 54 to transform a hemodynamic stenosis into a nonhemodynamic one. The technique's success lies mainly in selecting the stenosis to treat based on a study of the atherosclerotic plaque composition. This analysis serves to allocate patients to endovascular or surgical treatment, considering carotid artery stenting an alterative to thrombendarterectomy.
After selection carotid artery stenosis was found to depend on a wide range of plaque composition. In conclusion the stented vessels were generally dilated by the radial force of the stent alone with gradual stable transformation of the hemodynamic significance of the stenosis over time, offering a significantly good outcome. We believe that this approach is safe and feasible with success in selected patients with simplification of the technique and a reduction of patients risks and management costs. 
